Source:http://linkedlifedata.com/resource/pubmed/id/19716605
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-9-21
|
pubmed:abstractText |
Amongst the interleukin-6 (IL-6) family of cytokines, leukemia inhibitory factor (LIF) has been shown to promote trophoblast invasion and proliferation. In the present study interleukin-11 (IL-11), another member of the IL-6 family, was investigated for its role in regulating invasion, migration and proliferation of JEG-3 choriocarcinoma cells. JEG-3 cells, like extra villous trophoblast (EVT), express mRNA transcripts encoding IL-11 and IL-11 receptor-alpha (IL-11Ralpha). Treatment of JEG-3 cells with IL-11 led to an increase in invasion across Matrigel extracellular matrix without an increase in proliferation. There was a dose-dependent increase in activation of STAT3 under the influence of IL-11 with maximum Tyr705 phosphorylation by 10min. In addition, treatment of JEG-3 cells with IL-11 for 24h led to an increase in expression of unphosphorylated STAT1 and STAT3. Analysis of the nuclear fraction showed an increased localization of STAT3 following IL-11 treatment while STAT1 was absent. Silencing the expression of STAT3 by siRNA caused a 25% reduction in invasion compared to control cells, however this was not significant. Furthermore, treatment of STAT3-silenced JEG-3 cells with IL-11 led to a significant increase in invasion compared to STAT3-silenced cells without cytokine, but this was not significant compared to non-transfected control cells. Silencing the expression of gp130 but not of IL-6R abrogated the increase in invasiveness of JEG-3 cells following IL-11 treatment. In conclusion, activation and upregulation of STAT3 appears to be critical for the IL-11-mediated increase in invasiveness of JEG-3 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokine Receptor gp130,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-11,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1872-7603
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-11
|
pubmed:meshHeading |
pubmed-meshheading:19716605-Cell Line, Tumor,
pubmed-meshheading:19716605-Cell Proliferation,
pubmed-meshheading:19716605-Choriocarcinoma,
pubmed-meshheading:19716605-Cytokine Receptor gp130,
pubmed-meshheading:19716605-Female,
pubmed-meshheading:19716605-Humans,
pubmed-meshheading:19716605-Immunomodulation,
pubmed-meshheading:19716605-Interleukin-11,
pubmed-meshheading:19716605-Neoplasm Invasiveness,
pubmed-meshheading:19716605-Pregnancy,
pubmed-meshheading:19716605-RNA, Small Interfering,
pubmed-meshheading:19716605-Receptors, Interleukin-6,
pubmed-meshheading:19716605-STAT3 Transcription Factor,
pubmed-meshheading:19716605-Signal Transduction,
pubmed-meshheading:19716605-Uterine Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression.
|
pubmed:affiliation |
National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|